Psoriatic arthritis trials in United States

In United States 30 Also abroad 116

30 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.

Phase 1Taking people
Study to Evaluate the Pharmacokinetics (PK), Safety and Tolerability up to 6 Years of Intravenous (i.v.) Secukinumab in Pediatric Participants With Juvenile Psoriatic Arthritis (JPsA).
Where
Charlotte, Chicago, Cincinnati, Cleveland, El Paso, Gainesville, Loma Linda, New York, Pittsburgh, Portland, Salt Lake City
Age
2 years to 17 years
People
20
Run by
Novartis Pharmaceuticals
See details and how to joinNCT06751238
Phase 2Taking people
Study of Targeted Therapies for the Treatment of Adult Participants With Active Psoriatic Arthritis
Where
Austin, Avon Park, Chicago, Clearwater, Cumberland, Duncansville, Frisco, Houston, Huntington Beach, Lebanon, Memphis, Middleburg Heights, Orlando, San Antonio, Skokie, Tamarac, Tampa, Tomball, Willowbrook
Age
18 years and over
People
300 worldwide
Run by
AbbVie
See details and how to joinNCT06865105
Phase 2Taking people
A Study to Assess the Efficacy, Safety and Tolerability of DDY391 in Participants With Moderate to Severe Psoriatic Arthritis
Where
Colleyville, Corpus Christi, Duncansville, Huntington Beach, Katy, Memphis, Philadelphia, San Antonio
Age
18 years to 100 years
People
220
Run by
Novartis Pharmaceuticals
See details and how to joinNCT07801495
Phase 1Taking people
A Study to Learn if Bimekizumab Given in Different Ways is Safe and Moves Similarly Throughout the Body Over Time in Adults
Where
Albuquerque, Apple Valley, Baytown, Beckley, Bellevue, Chicago, Colleyville, Covina, Duncansville, Fort Collins, Fullerton, Jackson, Lansing, Mesquite, Murfreesboro, Ormond Beach, Peoria, Plano, Riverside, Rock Hill, San Leandro, South Miami, Spokane, Temecula, Upland, Vandalia, West Long Branch, Whittier, Zephyrhills
Age
18 years and over
People
392 worldwide
Run by
UCB Biopharma SRL
See details and how to joinNCT07290036
Phase 4Taking people
Impact of Glucagon-like Peptide-1 (GLP-1) Analogs on Disease Outcomes in Psoriatic Arthritis: A Pragmatic Randomized Controlled Trial
Where
Milwaukee
Age
18 years and over
People
22
Run by
Medical College of Wisconsin
See details and how to joinNCT07111494
Phase 3Taking people
A Long-term Extension (LTE) Study of Guselkumab in Pediatric Participants
Where
Atlanta, Cincinnati, Fort Worth, Indianapolis, Salt Lake City
Age
3 years to 64 years
People
196 worldwide
Run by
Janssen Research & Development, LLC
See details and how to joinNCT06663332 · EU 2023-509560-16-00
Phase 4Taking people
A Remotely Conducted Study to Assess Concentration of TREMFYA in Breast Milk of Lactating Women Who Are Receiving TREMFYA Therapeutically
Where
Chapel Hill
Age
18 years and over
People
10
Run by
Janssen Research & Development, LLC
See details and how to joinNCT07654751
No phaseTaking people
Observational Study of Pediatric Rheumatic Diseases: The CARRA Registry
Where
Akron, Albany, Ann Arbor, Atlanta, Augusta, Aurora, Birmingham, Boston, Burlington, Chapel Hill, Charleston, Charlotte, Chicago, Cincinnati, Cleveland, Columbus, Dallas, Durham, Fargo, Gainesville, Grand Rapids, Hackensack, Hartford, Hershey, Houston, Indianapolis, Iowa City, Jackson, Kansas City, Lake Success, Los Angeles, Louisville, Madison, Miami, Minneapolis, Morristown, Nashville, New Brunswick, New Haven, New York, Norfolk, Orlando, Palo Alto, Philadelphia, Phoenix, Pittsburgh, Portland, Providence, Rochester, Salt Lake City, San Diego, San Francisco, Seattle, Springfield, St Louis, St. Petersburg, Washington D.C., Wauwatosa, West Orange, Winston-Salem
Age
Up to 21 years
People
20,000 worldwide
Run by
Duke University
See details and how to joinNCT02418442
No phaseNot yet taking people in United States
Patient-Reported Outcomes Dashboard With Goal Setting to Support Shared Decision-Making in Inflammatory Arthritis
Where
Chicago
Age
18 years and over
People
160
Run by
Northwestern University
See details and how to joinNCT07865390
Phase 3Taking people
A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have Not Taken Biologic Medicines
Where
Albuquerque, Aventura, Baytown, Bellaire, Boca Raton, Brooklyn, Chandler, Clearwater, Cleveland, Cooper City, Coral Gables, Davie, Denver, Detroit, Fountain Valley, Grand Blanc, Hagerstown, Hialeah, Hickory, Houston, Howell, Jackson, Lake Charles, La Mesa, Lansing, Lubbock, Marietta, Mesquite, Miami, Middleburg Heights, Orlando, Orland Park, Ormond Beach, Phoenix, Plano, Plantation, Saint Clair Shores, Santa Fe, Sarasota, Schaumburg, Spokane, St Louis, Tamarac, Tampa, Thousand Oaks, Tujunga, Whittier, Wyomissing
Age
18 years and over
People
1,088 worldwide
Run by
Takeda
See details and how to joinNCT06671483 · EU 2024-513111-27-00
Phase 3Taking people
A Study to Evaluate the Drug Levels, Efficacy, and Safety of Deucravacitinib (BMS-986165) in Pediatric Participants With Juvenile Psoriatic Arthritis
Where
Austin, Chicago, Cincinnati, Cleveland, Indianapolis, Lancaster, North New Hyde Park
Age
5 years to 17 years
People
60 worldwide
Run by
Bristol-Myers Squibb
See details and how to joinNCT06869551 · EU 2024-517262-41-00
Phase 1Taking people
Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
Where
Atlanta, Baltimore, Bethesda, Birmingham, Boston, Chicago, City of Saint Peters, Columbus, Creve Coeur, Dallas, Detroit, Fairway, Fort Worth, Hays, Houston, Kansas City, Lawrence, Lee's Summit, Lexington, Mineola, New Brunswick, New Haven, New York, North Kansas City, Olathe, Overland Park, Palo Alto, Philadelphia, Pittsburg, Pittsburgh, Richardson, Richmond, Sacramento, Salina, Salt Lake City, St Louis, Topeka, Washington D.C., Westwood
Age
18 years and over
People
300 worldwide
Run by
National Cancer Institute (NCI)
See details and how to joinNCT03816345
Phase 1Taking people
A Study to Assess the Concentration of Bimekizumab in Mature Breast Milk From Mothers Receiving Treatment With Bimzelx® (Bimekizumab)
Where
Boston, Chapel Hill, Durham, Milwaukee, Santa Monica, South Miami
Age
18 years and over
People
20 worldwide
Run by
UCB Biopharma SRL
See details and how to joinNCT06888193 · EU 2024-518689-29-00
Phase 3Enrolling by invitation
A Study to Evaluate the Long-term Safety, Tolerability, and Efficacy of Subcutaneous Sonelokimab in Participants With Psoriatic Arthritis
Where
Avondale, Avon Park, Baytown, Charlotte, Clearwater, Duncansville, Jonesboro, Leland, Lubbock, Memphis, Mesa, Middleburg Heights, Phoenix, Scottsdale, Tampa, Tucson, Upland
Age
18 years and over
People
1,560
Run by
MoonLake Immunotherapeutics AG
See details and how to joinNCT07223138
Phase 3Taking people
Continuation Study of Zasocitinib in Adults With Psoriatic Arthritis
Where
Baytown, Bellaire, Denver, Fountain Valley, Hagerstown, Hialeah, Houston, Jackson, La Mesa, Lubbock, Mesquite, Middleburg Heights, Plantation, The Woodlands, Thousand Oaks, Tucson
Age
18 years and over
People
1,182 worldwide
Run by
Takeda
See details and how to joinNCT07286058 · EU 2025-522586-30-00
Phase 3Taking people
A Study to Assess Adverse Events, Change in Disease Activity, and How the Drug Moves Through the Body in Children With Juvenile Psoriatic Arthritis (jPsA) Receiving Subcutaneously Injected Risankizumab or Adalimumab
Where
Austin, Chapel Hill, Cleveland, Hollywood, Indianapolis, Little Rock, Miami, Minneapolis, New York, Valhalla, Washington D.C.
Age
5 years to 17 years
People
40 worldwide
Run by
AbbVie
See details and how to joinNCT06100744 · EU 2023-506026-36-00
Phase 4Taking people
Deucravacitinib-TNFi Combination Therapy for Difficult-to-Control Psoriatic Disease
Where
Dallas
Age
18 years to 65 years
People
128
Run by
University of Texas Southwestern Medical Center
See details and how to joinNCT07280702
No phaseTaking people
Creating Health Course Study for People With Rheumatological Conditions and Mood Disorders
Where
Iowa City
Age
18 years to 100 years
People
400
Run by
Terry L. Wahls
See details and how to joinNCT07180537
Phase 4Not yet taking people in United States
A Clinical Trial of Antiplatelets in Psoriasis
Where
New York
Age
18 years to 90 years
People
60
Run by
NYU Langone Health
See details and how to joinNCT07744191
Phase 2Taking people
Immunosuppressant Management in Rheumatology Patients Undergoing Elective Total Shoulder Arthroplasty
Where
New York
Age
18 years and over
People
80
Run by
NYU Langone Health
See details and how to joinNCT07138898
No phaseTaking people
Elucidating Shared Mechanisms Contributing to NAFLD and PsA Disease Severity With Guselkumab Therapy
Where
San Diego
People
20
Run by
University of California, San Diego
See details and how to joinNCT06586281
No phaseTaking people
Testing of an Educational Tool for Patients With Melanoma and Pre-Existing Autoimmune Disease Who Are Candidates for Immune Checkpoint Inhibitors
Where
Houston
Age
18 years and over
People
125
Run by
M.D. Anderson Cancer Center
See details and how to joinNCT04751396
Phase 4Taking people
A Study to Evaluate the Impact of Upadacitinib on Spondyloarthritis Outcomes in Patients With Active Psoriatic Arthritis
Where
Cleveland, Philadelphia, Portland
Age
18 years and over
People
100 worldwide
Run by
CARE ARTHRITIS LTD.
See details and how to joinNCT06454188 · EU 2023-510242-24-00
No phaseTaking people
Rheumatology Patient Registry and Biorepository
Where
New Haven
Age
18 years to 99 years
People
5,000
Run by
Yale University
See details and how to joinNCT04402086
No phaseTaking people
Unhide® Project: A Digital Health Platform to Collect Lifestyle Data for Brain Inflammation Research
Where
Delafield
Age
2 years and over
People
10,000
Run by
Brain Inflammation Collaborative
See details and how to joinNCT04806620